A Study of LY2090314 in Patients With Advanced or Metastatic Cancer

Clinical trial NCT01287520 · COMPLETED

Trial details

NCT number: NCT01287520
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2007-11-01
Primary completion: 2011-04-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.